Do activators of the κ-opioid receptor hold the potential for anti-arrhythmic drug development?

Crit Care Med. 2010 Dec;38(12):2419-20. doi: 10.1097/CCM.0b013e3181fd6916.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / pharmacology*
  • Anti-Arrhythmia Agents / therapeutic use
  • Biomarkers
  • Connexin 43 / drug effects*
  • Connexin 43 / metabolism
  • Disease Models, Animal
  • Drug Discovery
  • Myocardial Ischemia / blood
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / pathology
  • Myocardial Reperfusion Injury / drug therapy*
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / physiopathology
  • Phosphorylation
  • Rats
  • Receptors, Opioid, kappa / administration & dosage*

Substances

  • Anti-Arrhythmia Agents
  • Biomarkers
  • Connexin 43
  • Receptors, Opioid, kappa